Efficacy and Adverse Side Effects of two forms of Iron in prenatal micronutrient supplements (EASE-Iron) Trial
The EASE-Iron Study seeks to compare two forms of oral iron supplements during pregnancy for their effectiveness and tolerability, with the goal of informing more specific prenatal nutrition guidelines.
Trial status: Currently recruiting study participants
We are seeking:
- Pregnant individuals with a singleton pregnancy between 13-25 weeks gestation
- 19-42 years of age
What is involved?
You will be randomized to receive one of the two forms of iron supplements to take daily for the remainder of your pregnancy until delivery. You will also be provided with a daily prenatal multivitamin supplement which contains other important nutrients for pregnancy (e.g., folic acid). All study supplements have been approved by Health Canada.
The study will involve two in-person visits to the Food, Nutrition and Health Building at UBC or BC Women’s Hospital, where you will complete a health questionnaire and a blood sample will be collected. At the time of your delivery, hospital staff will collect umbilical cord blood and placenta tissue. Following delivery, you will also have the option to continue with the study and provide a human milk sample.
Compensation will be provided as a thank you for participating.
If you are interested, please email us at iron.study@ubc.ca OR scan this QR code to complete the eligibility screen and send us your contact details:
We will be recruiting participants until October 2025.
Instagram: @ubc_ironstudy
Facebook: UBC EASE-Iron Study
Research Coordinator: Lulu Pei, PhD Human Nutrition Candidate, UBC
Principal Investigator: Dr. Crystal Karakochuk, Associate Professor, Human Nutrition, UBC